THE inhalation of nebulized water or mist is commonly a part of the therapy of acute lower respiratory tract diseases such as bronchitis, bronchiolitis, and pneumonia. The use of mist therapy may require the hospitalization of the patient with its disadvantages. We therefore felt the efficacy of the agent should be investigated by using a standardized program to which nebulized water was added for randomly selected patients. Patients with prominent laryngeal involvement were excluded from the study. The duration of various clinical signs was used to compare the effects of the two programs.
Materials and Methods
With certain exceptions, all cases of lower respiratory tract infection in children over 2 weeks and under 3 years of age admitted to Wayne County General Hospital between July 1963 and June 1964 were placed on the study. The exceptions were those children with significant laryngeal obstruction, clearly defined chronic pulmonary or cardiac
KELSCH RC, BARR M, DeMUTH GR. Mist Therapy in Lower Respiratory Tract Infection: A Controlled Study. Am J Dis Child. 1965;109(6):495–499. doi:10.1001/archpedi.1965.02090020497004
Coronavirus Resource Center
Customize your JAMA Network experience by selecting one or more topics from the list below.
Create a personal account or sign in to: